Skip to content

Investigating immune cells in the lungs of people with severe community-acquired pneumonia

ImmuneCAP: T-cell responses in severe community acquired pneumonia, a pilot observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN19920744
Enrollment
15
Registered
2020-01-06
Start date
2019-12-21
Completion date
Unknown
Last updated
2020-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-acquired pneumonia Respiratory

Interventions

This observational study will compare consented patients with severe acute pneumonia to consented patients with and without lung injury. Once enrolled in the study, the participant will have a broncho

Sponsors

University of Oxford
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Admitted to a critical care setting in the Oxford University Hospital Trust 2. Mechanically ventilated for less than 72 h 3. Diagnosis of community acquired pneumonia has been made by the treating physicians based on the following criteria: 3.1. Symptoms and/or signs consistent with a lower respiratory tract infection 3.2. Radiological evidence of new onset consolidation on a chest x-ray or CT scan 4. Aged =16 years 5. Able to consent themselves or declaration obtained from a personal or professional consultee

Exclusion criteria

Exclusion criteria: 1. Previously included in the study 2. Hospital admission in the past 30 days (prior to this current presentation) 3. Long-term resident of a nursing home or other residential care facility

Design outcomes

Primary

MeasureTime frame
Quantity and phenotype of lung-derived T-cell populations measured using flow cytometry at a single timepoint within 72 h of the establishment of mechanical ventilation

Secondary

MeasureTime frame
Severity of respiratory failure and other organ failure using the sequential organ failure assessment (SOFA) score during the 90 days following admittance or the period from hospital admittance to discharge

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026